Motion Sickness Drug Market Growth, Size & Forecast by 2034
Motion Sickness Drug Market Size and Forecasts (2021 - 2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Anticholinergics, Antihistamines, Others); Distribution Channel (Retail Pharmacies, Online Pharmacies, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)
- Status : Data Released
- Report Code : TIPRE00022327
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Motion Sickness Drug Market is growing at a CAGR of 4.14% from 2026 to 2034
The major factors driving the Motion Sickness Drug market are:
1. Tourism and Travel Opportunities
2. The Rise in the Health Challenges Awareness
Development of Combination Therapies growth act as a opportunity for growth of the market in forecast period.
North America region dominated the Motion Sickness Drug market in 2025.
Retail Pharmacies segment, by distribution channel, dominated the market in 2025.
Players operating in the market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Consumer Healthcare Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co. Ltd, Baxter International Inc, CVS Health
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Motion Sickness Drug Market - By Treatment Type
1.3.2 Motion Sickness Drug Market - By Distribution Channel
1.3.3 Motion Sickness Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOTION SICKNESS DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MOTION SICKNESS DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MOTION SICKNESS DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. MOTION SICKNESS DRUG - GLOBAL MARKET OVERVIEW
6.2. MOTION SICKNESS DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MOTION SICKNESS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTICHOLINERGICS
7.3.1. Overview
7.3.2. Anticholinergics Market Forecast and Analysis
7.4. ANTIHISTAMINES
7.4.1. Overview
7.4.2. Antihistamines Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. MOTION SICKNESS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Retail Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. MOTION SICKNESS DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Motion Sickness Drug Market Overview
9.1.2 North America Motion Sickness Drug Market Forecasts and Analysis
9.1.3 North America Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Motion Sickness Drug Market
9.1.5.1.1 United States Motion Sickness Drug Market by Treatment Type
9.1.5.1.2 United States Motion Sickness Drug Market by Distribution Channel
9.1.5.2 Canada Motion Sickness Drug Market
9.1.5.2.1 Canada Motion Sickness Drug Market by Treatment Type
9.1.5.2.2 Canada Motion Sickness Drug Market by Distribution Channel
9.1.5.3 Mexico Motion Sickness Drug Market
9.1.5.3.1 Mexico Motion Sickness Drug Market by Treatment Type
9.1.5.3.2 Mexico Motion Sickness Drug Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Motion Sickness Drug Market Overview
9.2.2 Europe Motion Sickness Drug Market Forecasts and Analysis
9.2.3 Europe Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Motion Sickness Drug Market
9.2.5.1.1 Germany Motion Sickness Drug Market by Treatment Type
9.2.5.1.2 Germany Motion Sickness Drug Market by Distribution Channel
9.2.5.2 France Motion Sickness Drug Market
9.2.5.2.1 France Motion Sickness Drug Market by Treatment Type
9.2.5.2.2 France Motion Sickness Drug Market by Distribution Channel
9.2.5.3 Italy Motion Sickness Drug Market
9.2.5.3.1 Italy Motion Sickness Drug Market by Treatment Type
9.2.5.3.2 Italy Motion Sickness Drug Market by Distribution Channel
9.2.5.4 Spain Motion Sickness Drug Market
9.2.5.4.1 Spain Motion Sickness Drug Market by Treatment Type
9.2.5.4.2 Spain Motion Sickness Drug Market by Distribution Channel
9.2.5.5 United Kingdom Motion Sickness Drug Market
9.2.5.5.1 United Kingdom Motion Sickness Drug Market by Treatment Type
9.2.5.5.2 United Kingdom Motion Sickness Drug Market by Distribution Channel
9.2.5.6 Rest of Europe Motion Sickness Drug Market
9.2.5.6.1 Rest of Europe Motion Sickness Drug Market by Treatment Type
9.2.5.6.2 Rest of Europe Motion Sickness Drug Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Motion Sickness Drug Market Overview
9.3.2 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Motion Sickness Drug Market
9.3.5.1.1 Australia Motion Sickness Drug Market by Treatment Type
9.3.5.1.2 Australia Motion Sickness Drug Market by Distribution Channel
9.3.5.2 China Motion Sickness Drug Market
9.3.5.2.1 China Motion Sickness Drug Market by Treatment Type
9.3.5.2.2 China Motion Sickness Drug Market by Distribution Channel
9.3.5.3 India Motion Sickness Drug Market
9.3.5.3.1 India Motion Sickness Drug Market by Treatment Type
9.3.5.3.2 India Motion Sickness Drug Market by Distribution Channel
9.3.5.4 Japan Motion Sickness Drug Market
9.3.5.4.1 Japan Motion Sickness Drug Market by Treatment Type
9.3.5.4.2 Japan Motion Sickness Drug Market by Distribution Channel
9.3.5.5 South Korea Motion Sickness Drug Market
9.3.5.5.1 South Korea Motion Sickness Drug Market by Treatment Type
9.3.5.5.2 South Korea Motion Sickness Drug Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Motion Sickness Drug Market
9.3.5.6.1 Rest of Asia-Pacific Motion Sickness Drug Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Motion Sickness Drug Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Motion Sickness Drug Market Overview
9.4.2 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Motion Sickness Drug Market
9.4.5.1.1 South Africa Motion Sickness Drug Market by Treatment Type
9.4.5.1.2 South Africa Motion Sickness Drug Market by Distribution Channel
9.4.5.2 Saudi Arabia Motion Sickness Drug Market
9.4.5.2.1 Saudi Arabia Motion Sickness Drug Market by Treatment Type
9.4.5.2.2 Saudi Arabia Motion Sickness Drug Market by Distribution Channel
9.4.5.3 U.A.E Motion Sickness Drug Market
9.4.5.3.1 U.A.E Motion Sickness Drug Market by Treatment Type
9.4.5.3.2 U.A.E Motion Sickness Drug Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Motion Sickness Drug Market
9.4.5.4.1 Rest of Middle East and Africa Motion Sickness Drug Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Motion Sickness Drug Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Motion Sickness Drug Market Overview
9.5.2 South and Central America Motion Sickness Drug Market Forecasts and Analysis
9.5.3 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Motion Sickness Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Motion Sickness Drug Market
9.5.5.1.1 Brazil Motion Sickness Drug Market by Treatment Type
9.5.5.1.2 Brazil Motion Sickness Drug Market by Distribution Channel
9.5.5.2 Argentina Motion Sickness Drug Market
9.5.5.2.1 Argentina Motion Sickness Drug Market by Treatment Type
9.5.5.2.2 Argentina Motion Sickness Drug Market by Distribution Channel
9.5.5.3 Rest of South and Central America Motion Sickness Drug Market
9.5.5.3.1 Rest of South and Central America Motion Sickness Drug Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Motion Sickness Drug Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MOTION SICKNESS DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MOTION SICKNESS DRUG MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PERRIGO COMPANY PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PRESTIGE CONSUMER HEALTHCARE INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WELLSPRING PHARMACEUTICAL CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CALEB PHARMACEUTICALS INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYUNGMOON PHARM CO. LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BAXTER INTERNATIONAL INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CVS HEALTH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For